Sharanjeet Thind, MD is the section chief of Infectious Diseases and the co-chair of the Infection Prevention and Control committee at the VA Medical Center. She is also an Associate Professor of Medicine at the University of Oklahoma Health Sciences Center where she is heavily involved in teaching trainees and medical students. Her interests include treatment of bone and joint infections, invasive infections and endocarditis due to S. aureus and enterococci, and infections due to MDROs. Research interests include novel therapeutic approaches to treat severe S. aureus infections, optimal treatment of Clostridioides difficile and the management of osteomyelitis in diabetic patients.
Academic Section(s):
Infectious Diseases
Education:
Medical School: St. George's University, School of Medicine, Grenada, West Indies
Undergraduate: Bachelor of Science Degree, McMaster University, Hamilton, ON, Canada
Residency:
Internal Medicine, New York Medical College - Sound Shore Medical Center, New Rochelle, NY
Fellowship:
Infectious Diseases, State University of New York (SUNY), Downstate Medical Center, Brooklyn, NY
Clinical/Research Interests:
Research Projects:
- Investigation of Rifampin to Reduce Pedal Amputations for Osteomyelitis in Diabetics
- Optimal Treatment for Recurrent Clostridium Difficile Infection
- Enterococcal Bacteremia in Patients with COVID-19
Select Publications:
Recent Publications:
1. Gentry CA, Whitman, CM, Kliewer BS, Williams RJ 2nd, Thind SK. Propensity-matched analysis of the protective effect of ticagrelor versus clopidogrel on the risk of developing Staphylococcus aureus bacteremia. Int J Antimicrob Agents. 2023 Feb 9:106752. PMID: 36773940.
2. Gentry CA, Williams RJ 2nd, Whitman CM, Thind SK, Kliewer BS. Staphylococcus aureus bacteremia treatment outcomes in patients receiving ticagrelor versus a propensity-matched cohort receiving clopidogrel. Int J Antimicrob Agents. 2023 Feb 1:106743. PMID: 36736927
3. Gentry CA, Nguyen P, Thind SK, Kurdgelashvili G, Williams RJ 2nd. Characteristics and outcomes of US Veterans at least 65 years of age at high risk of severe SARS-CoV-2 infection with or without receipt of oral antiviral agents. J Infect. 2023 Jan 24:S0163-4453(23)00023-3. PMID: 36702309
4. Gentry CA, Thind SK, Williams RJ 2nd, Hendrickson SC, Kurdgelashvili G, Humphrey MB. Development of SARS-CoV-2 infection in patients with rheumatic conditions on hydroxychloroquine monotherapy vs. patients without rheumatic conditions: a retrospective, propensity-matched cohort study. Am J Med Sci. 2022 Sep 11:S0002-9629(22)00348-2 PMID: 36103912
5. Thind SK, Shibib DR, Gentry CA. The Effect of Nomenclature Revision of Streptococcus bovis to Streptococcus gallolyticus on Subsequent Colon Cancer Screening, Open Forum Infect Dis. 2021 Sep 23;8(9). PMID: 34568510
6. Khattab MH, Prodan CI, Vincent AS, Xu C, Jones KR, Thind SK, Rabadi M, Mithilesh S, Mathews E, Guthery L, Dale GL, Kirkpatrick AC. Increased procoagulant platelet levels are predictive of death in COVID-19. Geroscience. 2021 Aug;43(4):2055-2065. PMID: 34109507
7. Chehade AEH, Stephenson J, Floyd E, Keddissi JI, Abdo T, Thind SK, Stringfellow J, Youness HA. Proposed Alternative to Personal Protective Equipment N-95 Mask Due to Shortage in the COVID-19 Pandemic. J Emerg Manag. 2021 Special Issue on COVID-19;19(7):193-202. PMID: 34723379
8. Goetzinger JC, LaGrow AL, Shibib DR, Thind SK. Capnocytophaga canimorsus Bloodstream Infection Associated with an Urticarial Exanthem. Case Rep Infect Dis. 2021 Jun 10;2021:9932170. PMID: 34221523
9. Moseley JE Jr, Thind SK. Mycobacterium neoaurum Bloodstream Infection Associated with a Totally Implanted Subclavian Port in an Adult with Diabetes and History of Colon Cancer. Case Rep Infect Dis. 2020 Dec 31;2020:8878069. PMID: 33489390
10. Gentry CA, Humphrey MB, Thind SK, Hendrickson SC, Kurdgelashvili G, Williams RJ 2nd. Long-term hydroxychloroquine use in patients with rheumatic conditions and development of SARS-CoV-2 infection: a retrospective cohort study. Lancet Rheumatol. 2020 Nov;2(11):e689-e697. PMID: 32984847
11. Gentry CA, Nguyen PK, Thind S, Kurdgelashvili G, Skrepnek GH, Williams RJ 2nd. Fidaxomicin versus oral vancomycin for severe Clostridium difficile infection: a retrospective cohort study. Clin Microbiol Infect. 2019 Aug;25(8):987-993. PMID: 30583055